Ropeginterferon alfa-2b-njft is currently FDA-approved and marketed as BESREMi (R) for the treatment of adults with polycythemia vera (PV). The Company is seeking a ropeginterferon alfa-2b-njft label ...

The report warns that symptoms of hypervitaminosis D can include: drowsiness; confusion; apathy; psychosis; depression; stupor; coma; anorexia; abdominal pain; vomiting; constipation; peptic ulcers; ...

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

A pancreatitis-friendly diet includes high-energy, high-protein, calcium-rich, and antioxidant foods. Avoid high-fat, high-fiber, or anti-nutrient foods that may worsen your symptoms or block nutrient ...

New regimen for ropeginterferon alfa2b-njft enables patients to reach target dose faster, supporting positive clinical outcomes and enabling faster achievement of maintenance doseBURLINGTON, ...

Neurological autoimmune diseases happen when the immune system attacks the central nervous system (CNS) or peripheral nervous system (PNS). This can cause neurological symptoms, and about 30 ...

Induced pluripotent stem cell technology is a promising, rapidly evolving field with the potential to transform cell-based therapeutics across a range of disease areas that have significant unmet ...